Recommended Treatment After Buspirone and Hydroxyzine Failure
Start an SSRI (selective serotonin reuptake inhibitor) such as sertraline or escitalopram as your next pharmacological intervention. 1
Rationale for SSRIs as Next-Line Treatment
The evidence is clear that buspirone and hydroxyzine are not first-line agents for anxiety disorders. The 2023 Japanese Society of Anxiety and Related Disorders guidelines explicitly recommend SSRIs as the primary pharmacotherapy for anxiety disorders 1. Since you've already tried two second-line agents without success, it's time to move to evidence-based first-line treatment.
Why SSRIs Should Have Been First
- SSRIs have the strongest evidence base for treating generalized anxiety disorder, social anxiety disorder, and panic disorder 1, 2
- Buspirone, while FDA-approved for anxiety 3, has limited efficacy data and recent studies show it may not be effective in many anxiety presentations 4
- Hydroxyzine is an antihistamine with minimal robust evidence for anxiety treatment 5, 6
Specific SSRI Recommendations
First choice: Sertraline or Escitalopram
- These are preferred due to better tolerability profiles 5
- Escitalopram specifically shows superior tolerability compared to paroxetine 7
- Both have demonstrated efficacy in controlled trials 2, 8
Alternative SSRIs:
- Paroxetine (effective but more side effects)
- Fluvoxamine (covered by insurance in many countries)
If SSRIs Are Inadequate
Second medication trial: SNRI (Serotonin-Norepinephrine Reuptake Inhibitor)
Third medication trial options (if both SSRI and SNRI fail):
Critical Pitfalls to Avoid
Do not continue cycling through non-evidence-based agents. Buspirone and hydroxyzine are not first-line treatments, and their failure should prompt escalation to proven therapies, not lateral moves to other weak alternatives.
Benzodiazepines should be avoided for chronic anxiety treatment despite their rapid onset 5, 2. They carry risks of dependence, cognitive impairment (especially in older adults), and don't address the underlying disorder.
Allow adequate trial duration: SSRIs require 6-12 weeks at therapeutic doses to assess efficacy 2. Don't abandon treatment prematurely.
Dosing Considerations
Start at standard antidepressant doses and titrate based on response and tolerability. For example:
- Sertraline: Start 25-50 mg daily, target 50-200 mg
- Escitalopram: Start 5-10 mg daily, target 10-20 mg
- Venlafaxine: Start 37.5-75 mg daily, target 75-225 mg
Combination with Psychotherapy
While guidelines show mixed evidence for combining pharmacotherapy with CBT 1, cognitive behavioral therapy should be offered alongside medication when available, as it addresses anxiety through a different mechanism and may provide additional benefit 1, 2.
Duration of Treatment
Continue effective medication for 6-12 months after remission before considering discontinuation 2. Anxiety disorders are often chronic and require sustained treatment to prevent relapse.